Supreme Court Decision on FDA's Rules on Abortion Medication

SOURCE www.npr.org
The Supreme Court upheld the FDA's rules on abortion medication, ensuring continued access to mifepristone for medication abortions and miscarriage care. Doctors opposing abortion lost their legal challenge. More challenges may arise in the future, but for now, mifepristone remains available up to 10 weeks of pregnancy.

Key Points

  • Supreme Court unanimously upheld FDA's rules on abortion medication
  • Doctors opposing abortion lost their legal challenge
  • Mifepristone remains available for now up to 10 weeks of pregnancy

Pros

  • Continued access to mifepristone for medication abortions and miscarriage care
  • Doctors have federal conscience protections and don't have to prescribe mifepristone if they object

Cons

  • Anti-abortion groups disappointed with the decision and call for accountability
  • More challenges to mifepristone access are expected in the future